News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-19 5:33:58 am Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report BusinessWire
2024-03-17 5:50:16 am 30 Biggest Biotechnology Companies in the World Insider Monkey
2024-03-15 12:15:0 pm CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma Business Wire
2024-03-12 5:20:51 am Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript Insider Monkey
2024-03-11 7:36:0 am The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys Zacks
2024-03-11 4:0:0 am Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights Business Wire
2024-03-08 4:31:0 am 5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024 Zacks
2024-02-24 4:0:21 am An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 47% Undervalued Simply Wall St.
2024-02-23 4:15:0 am Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy Business Wire
   

Please consider a small donation if you think this website provides you with relevant information